Medpace Holdings (MEDP) Cash from Investing Activities Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Cash from Investing Activities Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -3,832.95% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -165.43% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -10.12% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.18% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 95.92% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -289.16% |
| 10 | Medpace Holdings | 17.20 Bn | 16.70 Bn | 201.64 Mn | -296.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -296.76% |
| Mar 31, 2026 | 32.43% |
| Dec 31, 2025 | 40.85% |
| Sep 30, 2025 | -1.66% |
| Jun 30, 2025 | 52.93% |
| Mar 31, 2025 | -494.74% |
| Dec 31, 2024 | 5.44% |
| Sep 30, 2024 | -21.06% |
| Jun 30, 2024 | -51.06% |
| Mar 31, 2024 | 126.62% |
| Dec 31, 2023 | 13.26% |
| Sep 30, 2023 | -20.52% |
| Jun 30, 2023 | 23.91% |
| Mar 31, 2023 | 15.21% |
| Dec 31, 2022 | -1.14% |
| Sep 30, 2022 | -8.89% |
| Jun 30, 2022 | -85.54% |
| Mar 31, 2022 | -16.13% |
| Dec 31, 2021 | -17.87% |
| Sep 30, 2021 | 23.64% |